Next report date
Report period
H2 2024
EPS estimate
−0.13EUR
Revenue estimate
3.00 MEUR
−0.300EUR
−18.08 MEUR
4.18 MEUR
31.24 M
About NIGHTINGALE HEALTH OYJ B
Sector
CEO
Teemu Pentti Suna
Website
Headquarters
Helsinki
Employees (FY)
88
Founded
2002
FIGI
BBG00ZKTRNZ8
Nightingale Health Oyj engages in the development of health data platform for healthcare service providers. Its blood analysis technology utilizes nuclear magnetic resonance and proprietary software to provide health data that links a person's lifestyle to disease risk. The company was founded by Antti Juhana Kangas, Juha Pekka Pöysä, Satu Saksman, Pasi Soininen, Teemu Pentti Suna, and Peter Würtz in 2002 and is headquartered in Helsinki, Finland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HEALTH is 1.860 EUR — it has decreased by 4.37% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange NIGHTINGALE HEALTH OYJ B stocks are traded under the ticker HEALTH.
NIGHTINGALE HEALTH OYJ B is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
HEALTH stock is 8.61% volatile and has beta coefficient of 0.52. Check out the list of the most volatile stocks — is NIGHTINGALE HEALTH OYJ B there?
HEALTH earnings for the last quarter are −0.16 EUR per share, whereas the estimation was −0.16 EUR resulting in a 3.44% surprise. The estimated earnings for the next quarter are −0.16 EUR per share. See more details about NIGHTINGALE HEALTH OYJ B earnings.
NIGHTINGALE HEALTH OYJ B revenue for the last quarter amounts to 1.94 M EUR despite the estimated figure of 2.02 M EUR. In the next quarter revenue is expected to reach 2.33 M EUR.
Yes, you can track NIGHTINGALE HEALTH OYJ B financials in yearly and quarterly reports right on TradingView.
HEALTH stock has risen by 18.85% compared to the previous week, the month change is a 77.14% rise, over the last year NIGHTINGALE HEALTH OYJ B has showed a 57.09% increase.
HEALTH net income for the last quarter is −8.53 M EUR, while the quarter before that showed −9.53 M EUR of net income which accounts for 10.50% change. Track more NIGHTINGALE HEALTH OYJ B financial stats to get the full picture.
Today NIGHTINGALE HEALTH OYJ B has the market capitalization of 112.38 M, it has increased by 22.74% over the last week.
No, HEALTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HEALTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NIGHTINGALE HEALTH OYJ B stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 88.00 employees. See our rating of the largest employees — is NIGHTINGALE HEALTH OYJ B on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NIGHTINGALE HEALTH OYJ B technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NIGHTINGALE HEALTH OYJ B stock shows the strong buy signal. See more of NIGHTINGALE HEALTH OYJ B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NIGHTINGALE HEALTH OYJ B future price: according to them, HEALTH price has a max estimate of 1.25 EUR and a min estimate of 1.25 EUR. Read a more detailed NIGHTINGALE HEALTH OYJ B forecast: see what analysts think of NIGHTINGALE HEALTH OYJ B and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NIGHTINGALE HEALTH OYJ B EBITDA is −11.69 M EUR, and current EBITDA margin is −282.19%. See more stats in NIGHTINGALE HEALTH OYJ B financial statements.